Keros to Receive $200 Million From Takeda In Connection to Elritercept License Deal

MT NewswiresJan 21 09:15 ET

Express News | Keros Therapeutics Global License Agreement With Takeda To Advance Elritercept Became Effective Jan. 16, Triggering $200M Payment From Takeda To Keros

BenzingaJan 21 08:11 ET

Takeda Canada Says Health Canada Granted Market Authorization for Fruzaqla

MT NewswiresJan 21 04:40 ET

Express News | Reported Sunday, Takeda's FRUZAQLA (Fruquintinib) Receives Health Canada Approval For Metastatic Colorectal Cancer

BenzingaJan 21 03:32 ET

The Nikkei average is up about 460 points, buoyed by rising U.S. stocks and a weaker yen = pre-noon on the 20th.

On the 20th, shortly after 10:03 AM, the Nikkei average stock price fluctuates around 38,910 yen, up about 460 yen from the previous weekend. At 9:56 AM, it reached 38,966.97 yen, which is up 515.51 yen. In the US stock market on the 17th local time, both the NY Dow and the Nasdaq Composite Index rebounded. In the Foreign Exchange market, movements to Buy back seem to have strengthened, supported by the depreciation of the yen against the dollar and euro. The yen-denominated settlement price of the Chicago Nikkei Futures is based on the Osaka market from the previous weekend on the 17th.

Kabushiki ShimbunJan 19 20:09 ET

ADR Japan stock ranking - Shin-Etsu Chemicals and others show a general Buy preference, Chicago is 325 yen higher than Osaka at 38,795 yen.

Japanese stocks of ADR (American Depositary Receipt), compared to the Tokyo Stock Exchange (calculated at 156.13 yen per dollar), have seen increases in Shin-Etsu Chemical <4063>, Advantest <6857>, Mizuho Financial Group <8411>, SoftBank Group <9984>, Tokyo Electron <8035>, Disco <6146>, Daiichi Sankyo <4568>, etc., with a general preference for Buy. The settlement price of Chicago Nikkei 225 Futures is 38,795 yen, up 325 yen compared to the Osaka daytime. The US stock market rebounded. The Dow Inc average rose by 334.70 dollars to 43,4.

Fisco JapanJan 19 16:20 ET